News
Kisunla, a newly approved Alzheimer's drug in Taiwan, would not be covered by the National Health Insurance (NHI) system, ...
Older Americans worried about cognitive decline can stay sharper for longer by exercising both their bodies and their brains and eating healthier. That’s according to initial results released Monday ...
LAS VEGAS ( FOX5) — The Lou Ruvo Center for Brain Health is offering a free, 8-week exploration art class for people living with dementia. Opening Minds through Art (OMA) is an award-winning, evidence ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus on existing disease areas.
The Senate Appropriations Committee rejected the Trump administration’s massive proposed funding cut to the National Institutes of Health (NIH), advancing a measure that would increase the agency’s ...
Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass of proteins ...
6h
PsyPost on MSNDementia diagnoses are often delayed for years, new study findsPeople with dementia face a long road to diagnosis, according to a comprehensive review published in the International ...
A month away from the PDUFA decision date for a Leqembi (lecanemab) subcutaneous autoinjector to be used for maintenance dosing for those with early Alzheimer’s disease, Eisai Co. Ltd. and Biogen Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results